Biotech | November 08, 2021
Meiji Seika Pharma to build new facility in Bangalore to expand CMO business
The new manufacturing facility will be built at a subsidiary of Adcock Ingram and will commence operation in March 23
The new manufacturing facility will be built at a subsidiary of Adcock Ingram and will commence operation in March 23
The product is synthetically developed as compared to the current process of drawing the same from blood plasma and is backed by a granted global patent
The release of this batch will secure the supply for hospitals and cancer centres that are involved in the clinical trials managed by the company
Torrent Pharmaceuticals Limited has reported consolidated financial results for the period ended September 30, 2021
Following the pre-NDA meeting with the U.S. FDA, the companies confirmed the current efficacy and safety databases are expected to be adequate for filing with confirmed pathways for MDD and PPD
The company has enabled a transformation across three core areas with an investment target of US $ 150 million
The 462,000 square foot state-of-the-art building targeting LEED Zero certification and is designed to be the most sustainable commercial lab building in Cambridge
Lonza, a global manufacturing partner to the pharma, biotech and nutrition industries, has announced it will invest in additional drug product manufacturing capabilities in Switzerland
In India, almost all approved vaccines are packed in FIOLAX glass made by SCHOTT
_256_384.png){kind=logo}
Results from these studies are expected to be released by 2023. If outcomes from these initial pilots are positive, the studies will be expanded to involve around 1 million participants in 2024 and 2025
Subscribe To Our Newsletter & Stay Updated
